How Can FGF23 be Targeted for Therapeutic Purposes?
Targeting FGF23 for therapeutic purposes can be beneficial in conditions like CKD and hypophosphatemic disorders. Potential approaches include:
Using monoclonal antibodies to inhibit FGF23 activity. Developing small molecule inhibitors to block FGF23 signaling pathways. Gene therapy to modulate FGF23 expression in specific tissues.
